Belgium· BE-AMP-SAM585404-00
Drovelis 3 mg - 14.2 mg
A drospirenone and estetrol product containing placebo, registered in Belgium by Gedeon Richter. The same ATC class is registered in 12 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Drospirenone and estetrol is registered in 12 of 19 countries.
Countries holding a registration under ATC G03AA18 (drospirenone and estetrol), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 7 of them publish a price we can compare per daily dose
Drospirenone and estetrol · ATC G03AA18
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Placebo
- Manufacturer
- Gedeon Richter
- Country
- Belgium (BE)
- ATC code
- G03AA18
- ATC class
- Drospirenone and estetrol
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 4
- be_apb4375424
- be_apb7731342
- be_apb4375416
- be_apb4375432
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Drospirenone and estetrol in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- GermanyP-Tabletten Weiß 7 Mm LichtensteinWinthrop Arzneimittel Gmbh
- NorwayPlacebo SASykehusapotekene HF
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- Germany · P-Tabletten Weiß 7 Mm Lichtenstein
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/14e07101-090f-4328-ac83-744336930122 GET /v1/drugs/14e07101-090f-4328-ac83-744336930122?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Drovelis 3 mg - 14.2 mg",
"name_fr": "Drovelis 3 mg - 14.2 mg",
"name_nl": "Drovelis 3 mg - 14.2 mg",
"amp_code": "SAM585404-00",
"strengths": [
"68.0000",
"14.2000",
"3.0000",
"40.0000"
],
"pack_count": 4,
"substances": [
"Placebo",
"Lactose Monohydrate",
"Estetrol Monohydrate",
"Estetrol",
"Drospirenone",
"Sodium Starch Glycolate"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Drospirenone and Estetrol",
"authorisation_numbers": [
"EU/1/21/1547/001",
"EU/1/21/1547/002",
"EU/1/21/1547/004",
"EU/1/21/1547/003"
]
}See everything about drospirenone and estetrol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.